What is Euro-Med Laboratories Philippines Gross Margin %?
Euro-Med Laboratories PhilippinesPHS:EURO 82 Gross Margin % is 36.67% as of Mar. 2026, which is 2% above its 10-year median of 35.86. GuruFocus rates PHS:EURO with a GF Score™ of 82/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks worse than 70.91% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Euro-Med Laboratories Philippines had a gross margin of 36.67% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Euro-Med Laboratories Philippines Gross Margin % Related Terms
Euro-Med Laboratories Philippines Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHS:EURO vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Euro-Med Laboratories Philippines (PHS:EURO) has a Gross Margin % of 36.67% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. This is near median its historical median of 35.86. Over the past decade, Euro-Med Laboratories Philippines' Gross Margin % has ranged from 33.72 to 42.46. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #663 out of 935 companies in the Drug Manufacturers industry, placing it in the top 70.9%.
Is Euro-Med Laboratories Philippines' Gross Margin % too high?
Euro-Med Laboratories Philippines' current Gross Margin % of 36.67% is near median its 10-year median of 35.86. Over the past 10 years, this metric has ranged from a low of 33.72 to a high of 42.46. The Drug Manufacturers industry median Gross Margin % is 48.54. Euro-Med Laboratories Philippines' value of 36.67% is 24.5% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #663 out of 935 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #663 out of 935 companies for Gross Margin %. This places Euro-Med Laboratories Philippines in the lower half of its industry. The industry median Gross Margin % is 48.54. Euro-Med Laboratories Philippines' value of 36.67% is 24.5% below this benchmark. Historically, Euro-Med Laboratories Philippines' own Gross Margin % has ranged from 33.72 to 42.46 over the past decade. While the company's 10-year median is 35.86 vs. the industry median of 48.54, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Gross Margin % of 36.67% is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Gross Margin % is 36.67%, which is near median its own 10-year median of 35.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.07 — trading 4.9% above its estimated fair value. The current Gross Margin % is 36.67%, which is near median its 10-year median of 35.86 and 24.5% below the Drug Manufacturers industry median of 48.54. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Gross Margin % is 36.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.07 is trading 4.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Gross Margin %: 36.67% (near median its 10-year median of 35.86)
GF Value™: ₱1.02 vs. price of ₱1.07 (4.9% above fair value)
Industry Position: 24.5% below the Drug Manufacturers median (#663 of 935)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score
Get the complete analysis for PHS:EURO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
